Raheleh Salari, Ph.D.
Affiliations: | 2010 | Simon Fraser University, Burnaby, British Columbia, Canada |
Area:
Computer Science, General BiophysicsGoogle:
"Raheleh Salari"Parents
Sign in to add mentor| Funda Ergun | grad student | 2010 | Simon Fraser | |
| (Computational Methods for RNA-RNA Interaction Prediction.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wu H, Kalashnikova E, Mehta S, et al. (2020) Characterization of clonal hematopoiesis of indeterminate potential mutations from germline whole exome sequencing data. Journal of Clinical Oncology. 38: 1525-1525 |
| Magbanua MJM, Brown-Swigart L, Hirst G, et al. (2020) Abstract P5-01-04: Personalized monitoring of circulating tumor DNA during neoadjuvant therapy in high-risk early stage breast cancer reflects response and risk of metastatic recurrence Cancer Research. 80 |
| Reinert T, Henriksen TV, Christensen E, et al. (2019) Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer. Jama Oncology |
| Christensen E, Birkenkamp-Demtröder K, Sethi H, et al. (2019) Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1802052 |
| Coombes C, Page K, Salari R, et al. (2019) Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Magbanua M, Brown-Swigart L, Hirst G, et al. (2019) Abstract PD2-01: Personalized serial circulating tumor DNA (ctDNA) analysis in high-risk early stage breast cancer patients to monitor and predict response to neoadjuvant therapy and outcome in the I-SPY 2 TRIAL Cancer Research. 79 |
| Coombes R, Armstrong AC, Ahmed S, et al. (2019) Abstract P4-01-02: Early detection of residual breast cancer through a robust, scalable and personalized analysis of circulating tumour DNA (ctDNA) antedates overt metastatic recurrence Cancer Research. 79 |
| Christensen E, Birkenkamp-Demtröder K, Sethi H, et al. (2019) Abstract 913: Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma Cancer Research. 79: 913-913 |
| Jacobs SA, Sethi H, Kolveska T, et al. (2019) Analysis of circulating tumour DNA for early relapse detection in stage III colorectal cancer after adjuvant chemotherapy Annals of Oncology. 30 |
| Correa A, Connolly DC, Balcioglu M, et al. (2019) Presence of circulating tumour DNA in surgically resected renal cell carcinoma is associated with advanced disease and poor patient prognosis Annals of Oncology. 30 |